NAMPT and systemic lupus erythematosus: NAMPT/visfatin, a potent mediator of inflammation, was increased in several autoimmune diseases, such as, rheumatoid arthritis, systemic lupus erythematosus, ulcerative colitis, Crohn’s disease, and psoriasis [12–17].